Dr. Mark Adams
Claim this profileAlliance for Multispecialty Research, LLC
Studies Tobacco Use
Studies Migraine
18 reported clinical trials
34 drugs studied
Affiliated Hospitals
Clinical Trials Mark Adams is currently running
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
PXVX0317 Booster
for Chikungunya
The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunogenicity of CHIKV VLP vaccine in adult and adolescent participants and to evaluate CHIKV VLP booster vaccine induced serum neutralizing antibody (SNA) response at 3, 4, or 5 years post-initial CHIKV VLP vaccination.
Recruiting1 award Phase 3
More about Mark Adams
Clinical Trial Related3 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Mark Adams has experience with
- Placebo
- Ensifentrine
- Dihydroergotamine
- Product A: Non-Combusted Cigarette Variant 42001402 And Product Use Mode B
- Product B: Non-Combusted Cigarette Variant 42001399 And Product Use Mode B
- Product D: Non-Combusted Cigarette Variant 40007386 And Product Use Mode B
Breakdown of trials Mark Adams has run
Tobacco Use
Migraine
Smoking
- BAT3221032: A Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects
- CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches
Tobacco Smoking
- BAT3221032: A Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects
- CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches
Cardiovascular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Adams specialize in?
Mark Adams focuses on Tobacco Use and Migraine. In particular, much of their work with Tobacco Use has involved treating patients, or patients who are undergoing treatment.
Is Mark Adams currently recruiting for clinical trials?
Yes, Mark Adams is currently recruiting for 5 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Mark Adams has studied deeply?
Yes, Mark Adams has studied treatments such as Placebo, Ensifentrine, Dihydroergotamine.
What is the best way to schedule an appointment with Mark Adams?
Apply for one of the trials that Mark Adams is conducting.
What is the office address of Mark Adams?
The office of Mark Adams is located at: Alliance for Multispecialty Research, LLC, Lexington, Kentucky 40509 United States. This is the address for their practice at the Alliance for Multispecialty Research, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.